Clinical Trial Update: Cholecalciferol Intervention to Prevent Respiratory Infections Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cholecalciferol (vitamin D3) to prevent respiratory infections has completed. The study involved individuals with vitamin D …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection
• Vitamin Deficiency

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Menzies Institute for Medical Research | Conditions: Respiratory Tract Infection, Vitamin D Deficiency | Phase 2 | Status: COMPLETED